ITEMS IN AFP WITH KEYWORD:

Atrial Fibrillation

Oct 15, 2012 Issue
Rivaroxaban (Xarelto) for Prevention of Thromboembolic Events [STEPS]

In patients at high risk of stroke because of nonvalvular atrial fibrillation, rivaroxaban is as safe and effective as warfarin. However, it should not be used in patients at risk of stroke for reasons other than nonvalvular atrial fibrillation until research shows its relative safety and effectiveness.


Oct 15, 2012 Issue
Chronic Atrial Fibrillation [Clinical Evidence Handbook]

What are the effects of oral medical treatments to control heart rate in patients with chronic (longer than one week) nonvalvular atrial fibrillation? What is the effect of different treatment strategies for patients with persistent nonvalvular atrial fibrillation?


Dec 15, 2011 Issue
Dabigatran (Pradaxa) for Prevention of Stroke in Atrial Fibrillation [STEPS]

Dabigatran is superior to warfarin for stroke prevention in patients with atrial fibrillation, with similar rates of major bleeding. Because it does not require laboratory monitoring, dabigatran therapy is less complicated than warfarin therapy, but it costs significantly more.


Dec 1, 2011 Issue
Updated Guidelines on Management of Atrial Fibrillation from the ACCF/AHA/HRS [Practice Guidelines]

The American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), and the Heart Rhythm Society (HRS) have released updated guidelines for the management of atrial fibrillation. Since the previous guidelines were issued in 2006, new data have become available on strict versu...


Jan 1, 2011 Issue
Atrial Fibrillation: Diagnosis and Treatment [Article]

Atrial fibrillation is the most common cardiac arrhythmia. It impairs cardiac function and increases the risk of stroke. The incidence of atrial fibrillation increases with age. Key treatment issues include deciding when to restore normal sinus rhythm, when to control rate only, and how to prevent t...


Nov 15, 2009 Issue
Catheter Ablation of Supraventricular Arrhythmias and Atrial Fibrilation [Article]

Supraventricular arrhythmias and atrial fibrillation are common and persistent cardiac rhythm disturbances. Catheter-based ablation is an effective therapy that has durable therapeutic end points and a low complication rate.


Sep 1, 2007 Issue
Atrial Fibrillation (Chronic) [Clinical Evidence Handbook]

What are the effects of oral medical treatments to control heart rate in persons with chronic (longer than one week) nonvalvular atrial fibrillation? What is the effect of different treatment strategies for persons with persistent nonvalvular atrial fibrillation?


Jun 1, 2007 Issue
Adenosine vs. Calcium Channel Blockers for Supraventricular Tachycardia [Cochrane for Clinicians]

Adenosine and verapamil (Calan, Isoptin SR) are equally effective for treating acute supra-ventricular tachycardia in adults. Patients treated with adenosine have a higher rate of minor, transient adverse effects than patients treated with verapamil; however, rare but serious adverse effects may be ...


May 15, 2007 Issue
Joint Guideline Released for Atrial Fibrillation [Practice Guidelines]

A joint guideline for atrial fibrillation has been released by the American College of Cardiology (ACC), American Heart Association (AHA), and European Society of Cardiology (ESC). This guideline assists physicians by describing diagnosis and management options.


Dec 1, 2005 Issue
Pharmacologic Cardioversion for Atrial Fibrillation and Flutter [Cochrane for Clinicians]

There is no evidence that rhythm control in older patients with atrial fibrillation is more effective than rate control for improving patient-oriented outcomes.


Pages: Previous 1 2 3 Next


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now